Documents & Downloads

SARS-CoV-2 Mpro-IN-44

Mpro Inhibitor

SARS-CoV-2 Mpro-IN-44 is a potent inhibitor of the main protease (Mpro) in coronaviruses, including SARS-CoV-2 and porcine epidemic diarrhea virus (PEDV), exhibiting an IC50 of less than 0.6 μM. This compound effectively disrupts viral protease activity by improving interactions with conserved sites of the enzyme, thereby offering broad-spectrum antiviral efficacy. SARS-CoV-2 Mpro-IN-44 is suitable for research in the development of therapeutic agents targeting coronavirus infections.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	3020713-53-2
Applications	Mpro Inhibitor
Formula	C₂₉H₁₉Cl₂FN₈O₄S
Molecular Weight	665.48
SMILES	N#CC1=CC=C(OC2=CC(F)=C(Cl)C=C2CN3C(N(CC4=CC=CNC4=O)C(N/C3=N\C5=CC6=CN(C)N=C6C=C5Cl)=O)=O)S1

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.